Fig. 2From: miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLCmiR-181b enhances the sensitivity of NSCLC cells to DDP. After transfection with miR-181b mimics, miR-181b inhibitors, or the control, A549/DDP and A549 spheres were analysed. a IC50 values by CCK analysis with different concentrations of cisplatin, b apoptotic percentage by flow cytometry, and c Bcl-2 and cleaved caspase-3 expression by Western blotting. Data are presented as the mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001Back to article page